Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy

Nagsen Gautam, Upal Roy, Shantanu Balkundi, Pavan Puligujja, Dongwei Guo, Nathan Smith, Xin Ming Liu, Benjamin Lamberty, Brenda Morsey, Howard S. Fox, Jo Ellyn McMillan, Howard E. Gendelman, Yazen Alnouti

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Long-acting injectable nanoformulated antiretroviral therapy (nanoART) was developed with the explicit goal of improving medicine compliance and for drug targeting of viral tissue reservoirs. Prior nanoART studies completed in humanized virusinfected mice demonstrated sustained antiretroviral responses. However, the pharmacokinetics (PK) and tissue distribution of nanoART were not characterized. To this end, the PK and tissue distribution of nanoformulated atazanavir (ATV) and ritonavir (RTV) injected subcutaneously or intramuscularly in mice and monkeys were evaluated. Fourteen days after injection, ATV and RTV levels were up to 13-, 41-, and 4,500-fold higher than those resulting from native-drug administration in plasma, tissues, and at the site of injection, respectively. At nanoART doses of 10, 50, 100, and 250 mg/kg of body weight, relationships of moreand less-than-proportional increases in plasma and tissue levels with dose increases were demonstrated with ATV and RTV. Multiple-dose regimens showed serum and tissue concentrations up to 270-fold higher than native-drug concentrations throughout 8 weeks of study. Importantly, nanoART was localized in nonlysosomal compartments in tissue macrophages, creating intracellular depot sites. Reflective data were obtained in representative rhesus macaque studies. We conclude that nanoART demonstrates blood and tissue antiretroviral drug levels that are enhanced compared to those of native drugs. The sustained and enhanced PK profile of nanoART is, at least in part, the result of the sustained release of ATV and RTV from tissue macrophases and at the site of injection.

Original languageEnglish (US)
Pages (from-to)3110-3120
Number of pages11
JournalAntimicrobial Agents and Chemotherapy
Volume57
Issue number7
DOIs
StatePublished - Jul 2013

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy'. Together they form a unique fingerprint.

  • Cite this